BioSpace News Archive

Medivir AB informs that new data from the phase II program of MIV-711, will be presented during the Osteoarthritis Research Society International world congress, which will take place 2-5 May in Toronto, Canada.

CVS Health joins a growing list of companies to Quit Big Tobacco, a Vital Strategies initiative aimed at taking money, talent and expertise away from the tobacco and e-cigarette industries

Company expects to initiate Phase 1 / 2 study ‘Unite-CNM’ in 2H2019

Profitability is expected to improve from Q2 and on

Varian announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate brachytherapy treatments with the Bravos™ afterloader system.

Generated $538 million of gross proceeds from common stock issuances at an average price of $74.69 per share

Dispelix announced the launch of the DPX 30° see-through near-eye display for use in augmented reality and mixed reality eyewear and headsets.

Management to discuss new partner pharmacy program and expanded access to in-office direct channel

Zymeworks Inc. announced it has expanded its leadership team with the hiring of three new vice presidents to support the Company’s expanded global clinical development: Mark Hollywood, Senior Vice President, Technical and Manufacturing Operations; Neil Josephson, M.D., Vice President, Clinical Research; and Bruce Hart, Ph.D., Vice President, Regulatory Affairs.

New BD ChloraPrep™ Skin Preparation is the Only Commercially Available CHG Antiseptic Skin Preparation with Sterile Solution Designation in the U.S.